\nComisia European\u0103 a ajuns la acorduri cu grupurile farmaceutice Roche \u015fi Merck KGaA pentru a putea garanta stocuri de tratamente experimentale anti-Covid-19, afirm\u0103 surse din cadrul Executivului Uniunii Europene, citate de agen\u0163ia de pres\u0103 Reuters.<\/p>\n
\nAcordurile se refer\u0103 la medicamentul antiartrit\u0103 RoActemra, produs de Roche, \u015fi la medicamentul Rebif, contra sclerozei multiple, fabricat de Merck – ambele considerate ca poten\u0163iale tratamente anti-Covid-19. Contractele prev\u0103d asigurarea de stocuri pentru toate cele 27 de state membre ale Uniunii Europene.<\/p>\n
\nOficialii cita\u0163i, care au preferat s\u0103 men\u0163in\u0103 anonimatul, nu au dezv\u0103luit termenii contractelor.<\/p>\n
\nUnele \u0163\u0103ri membre UE au cerut \u00een mai s\u0103 aib\u0103 posibilitatea achizi\u0163ion\u0103rii celor dou\u0103 medicamente. Roche efectueaz\u0103 \u00een prezent teste clinice pe 330 de pacien\u0163i cu medicamentul Actemra, denumit RoActemra pe unele pie\u0163e. \u00cen China, acest medicament a fost utilizat la pacien\u0163i care au reac\u0163ii imune severe generate de infectarea cu noul coronavirus. Medicamentul a fost testat \u015fi \u00een combina\u0163ie cu antiviraulul Remdesivir, produs de Gilead, singurul tratament autorizat p\u00e2n\u0103 acum \u00een spa\u0163iul UE \u00eempotriva Covid-19.<\/p>\n
\nRebif a fost produs de firma biotehnologic\u0103 elve\u0163ian\u0103 Serono, \u00eenainte de a fi cump\u0103rat\u0103 de Merck.<\/p>\n
\nComisia European\u0103 negociaz\u0103 \u015fi cu firma american\u0103 Gilead pentru a ob\u0163ine doze de Remdesivir pentru statele membre UE.<\/p>\n","protected":false},"excerpt":{"rendered":"
Comisia European\u0103 a ajuns la acorduri cu grupurile farmaceutice Roche \u015fi Merck KGaA pentru a putea garanta stocuri de tratamente experimentale anti-Covid-19, afirm\u0103 surse din cadrul Executivului Uniunii Europene, citate de agen\u0163ia de pres\u0103 Reuters. Acordurile se refer\u0103 la medicamentul antiartrit\u0103 RoActemra, produs de Roche, \u015fi la medicamentul Rebif, contra sclerozei multiple, fabricat de Merck […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[46034,7861,12923,349],"class_list":["post-184530","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-coronavirus","tag-reuters","tag-tratament","tag-ue"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/184530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=184530"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/184530\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=184530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=184530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=184530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}